| A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects (NCT05529849) | Endevica Bio | 2022-07-12 |
| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma (NCT05376592) | Wake Forest University Health Sciences | 2022-06-17 |
| Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms (NCT05307367) | University of Copenhagen | 2022-04-01 |
| Ruxolitinib for Cancer Cachexia (NCT04906746) | Tu Dan | 2022-02-23 |
| The Impact of Oligo-Fucoidan in Cancer Cachexia and Sarcopenia (NCT05623852) | Taipei Medical University WanFang Hospital | 2022-01-30 |
| Vitamin K2 Supplements for Muscle Recovery (NCT05161975) | Lithuanian Sports University | 2021-12-15 |
| Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV) (NCT06028321) | Actimed Therapeutics Ltd | 2021-11-26 |
| Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia (NCT05028192) | University of Turin, Italy | 2021-09-27 |
| MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients (NCT04600154) | National Taiwan University Hospital | 2021-08-10 |
| Patient Recorded Indexing Measurements (NCT05899205) | Academisch Ziekenhuis Maastricht | 2021-06-01 |
| Early Diagnosis of Gastric Cancer Cachexia (NCT06277986) | Xijing Hospital | 2021-06-01 |
| Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia (NCT04803305) | Pfizer | 2021-05-11 |
| A Phase 1 Study of AV-380 in Healthy Subjects (NCT04815551) | AVEO Pharmaceuticals, Inc. | 2021-02-22 |
| Skeletal Muscle Wasting in SARS-CoV-2 (NCT04698798) | Hasselt University | 2021-01-02 |
| PeRfusion Emergency VEiNlite Transillumination (NCT04628975) | Central Hospital, Nancy, France | 2021-01-01 |
| Mechanism of Sarcopenia in Heart Failure (NCT05063955) | Aarhus University Hospital | 2020-12-02 |
| The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy (NCT04585841) | University of Copenhagen | 2020-12-01 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. (NCT04299048) | Pfizer | 2020-11-17 |
| The Investigation of the Mechanism of Cachexia Occurrence for Patients With Gastrointestinal Cancer (NCT04594863) | Peking Union Medical College Hospital | 2020-11-01 |
| Multimodal Program for Cancer Related Cachexia Prevention (NCT04627376) | Cyprus University of Technology | 2020-09-24 |
| Analysis of Retinochoroidal Vasculature in Underweight Women Using Optical Coherence Tomography Angiography (NCT04631978) | Akdeniz University | 2020-06-01 |
| Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) (NCT04907864) | Kil Yeon Lee | 2020-01-31 |
| Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients (NCT03982082) | M.D. Anderson Cancer Center | 2019-04-12 |
| Novel Form of Nutritional Supplementation in Cancer Patients (NCT03561610) | University of Erlangen-Nürnberg Medical School | 2018-05-01 |
| Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) (NCT03359473) | GlaxoSmithKline | 2018-02-28 |
| Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects (NCT03392116) | NGM Biopharmaceuticals, Inc | 2018-01-29 |
| Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia (NCT03207724) | Andrew Hendifar, MD | 2017-10-16 |
| WB-EMS and Individualized Nutritional Support in Gynecological Cancer Patients (NCT03570242) | University of Erlangen-Nürnberg Medical School | 2017-07-01 |
| Mitochondrial Respiratory Function in Mammalian Skeletal Muscle (NCT02650570) | The University of Texas Medical Branch, Galveston | 2017-02-14 |
| Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy (NCT03042442) | Iuliu Hatieganu University of Medicine and Pharmacy | 2017-01-01 |
| Methods for Nutritional Assessment in Cirrhosis (NCT02926261) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2016-12-01 |
| Food Reward in Cachexia Induced by Acute or Chronic Disease (NCT02798003) | Maastricht University Medical Center | 2016-12-01 |
| Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer. (NCT02968979) | Chugai Pharma France | 2016-07-01 |
| The Effects of a 12 Week Home-based Exercise Intervention on Physical Performance in Patients With Cancers of the Gastrointestinal Tract With Pre- Cachexia or Cachexia (NCT04802486) | University of Rochester | 2016-06-29 |
| Perioperative Glutamine Supplementation and Cachexia (NCT05023499) | National Taiwan University Hospital | 2016-01-01 |
| Body Composition Measurements in Chronic Heart Failure (NCT02686866) | Hungarian Institute of Cardiology | 2016-01-01 |
| Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia (NCT03881826) | Université Catholique de Louvain | 2015-12-04 |
| Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers (NCT03162042) | University Hospital, Clermont-Ferrand | 2015-11-02 |
| Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia (NCT02580422) | Indiana University | 2015-10-01 |
| Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078 (NCT02567773) | GlaxoSmithKline | 2015-09-01 |
| Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia (NCT02515032) | Smartfish AS | 2015-07-01 |
| Brown Adipose Tissue Activity and Energy Metabolism in Cachexia (NCT02500004) | Maastricht University Medical Center | 2015-06-01 |
| Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia (NCT02442908) | Smartfish AS | 2015-05-01 |
| Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients (NCT02400398) | Andrew Hendifar, MD | 2015-04-27 |
| Electronic-health Application To Measure Outcomes REmotely Clinical Trial (NCT02418546) | Massachusetts General Hospital | 2015-04-01 |
| Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy (NCT02330926) | Norwegian University of Science and Technology | 2015-04-01 |
| Effectiveness of Nutritional Counselling and "Improved Atta" Supplementation in Cachexic Adult Indian Cancer Patients (NCT02561143) | University of Westminster | 2015-04-01 |
| Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer? (NCT02416570) | University of Nottingham | 2015-04-01 |
| Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients (NCT02802540) | Instituto Nacional de Cancerologia de Mexico | 2014-12-01 |
| A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers (NCT01962454) | GlaxoSmithKline | 2014-05-05 |
| Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy (NCT01941810) | Wake Forest University Health Sciences | 2014-02-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses (NCT02045940) | GlaxoSmithKline | 2014-01-20 |
| Impact of Nutritional Intervention in Indian Female Cancer Cachexia Patients (NCT02350855) | University of Westminster | 2013-12-01 |
| Retrospective Review of Cachexia in Lung and Gastrointestinal Cancer Patients (NCT03606317) | University of Texas Southwestern Medical Center | 2013-11-26 |
| Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation (NCT02017925) | Ohio State University Comprehensive Cancer Center | 2013-10-01 |
| Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS) (NCT01865903) | Oslo University Hospital | 2013-06-15 |
| Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase II (NCT01694602) | The University of Texas Medical Branch, Galveston | 2012-11-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects (NCT01696604) | GlaxoSmithKline | 2012-09-26 |
| Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth (NCT01647841) | Cornell University | 2012-04-01 |
| Development of a Screening Tool to Detect and Stage Cachectic Cancer Patients (NCT01533909) | Universitaire Ziekenhuizen KU Leuven | 2012-03-01 |
| Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure (NCT01829880) | The University Clinic of Pulmonary and Allergic Diseases Golnik | 2011-10-01 |
| A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study (NCT01419145) | Norwegian University of Science and Technology | 2011-10-01 |
| Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas (NCT01433263) | Novartis Pharmaceuticals | 2011-08-01 |
| Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) (NCT01387269) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) (NCT01395914) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2) (NCT01387282) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers (NCT01397214) | Boryung Pharmaceutical Co., Ltd | 2011-07-01 |
| Prevalence of Cachexia in Patients Undergoing Chemotherapy (NCT01939340) | Charite University, Berlin, Germany | 2010-04-01 |
| Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients (NCT00851448) | Fresenius Kabi | 2009-10-01 |
| Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients (NCT01015274) | The University of Texas Medical Branch, Galveston | 2009-10-01 |
| Metabolism of Lipids in Advanced Cancer (NCT00962234) | AHS Cancer Control Alberta | 2009-10-01 |
| Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients (NCT00994669) | The University of Texas Medical Branch, Galveston | 2009-10-01 |
| Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma (NCT00878995) | The University of Texas Medical Branch, Galveston | 2009-06-03 |
| Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study (NCT00933361) | Cantonal Hospital of St. Gallen | 2009-06-01 |
| Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients (NCT00852020) | Fresenius Kabi | 2009-04-01 |
| Strength Training on Pancreatic Cancer (NCT01395563) | German Cancer Research Center | 2009-01-01 |
| Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer (NCT00972634) | Norwegian University of Science and Technology | 2008-10-01 |
| Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia (NCT00866970) | CSL Behring | 2008-09-01 |
| SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD) (NCT00698828) | Daiichi Sankyo | 2008-05-15 |
| Multimodal Treatment Strategy for Cancer Cachexia (NCT00625742) | M.D. Anderson Cancer Center | 2008-02-01 |
| Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer (NCT00535015) | Anaborex | 2007-10-01 |
| Haelan and Nutrition in Cancer Patients (NCT00558558) | M.D. Anderson Cancer Center | 2007-10-01 |
| Screening to Predict Weight Loss in Patients With Cancer (NCT00710632) | Queen's Medical Center | 2007-09-01 |
| Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. (NCT00467844) | GTx | 2007-05-01 |
| Regimen for the Treatment of Cachexia in Subjects With NSCLC (NCT00527319) | Vicus Therapeutics | 2007-01-01 |
| Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension (NCT00637806) | Par Pharmaceutical, Inc. | 2006-06-01 |
| Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients (NCT00637728) | Par Pharmaceutical, Inc. | 2006-06-01 |
| Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy (NCT00486304) | UNC Lineberger Comprehensive Cancer Center | 2006-02-01 |
| Pharmacokinetics and Safety of Transdermal Megestrol Acetate (NCT00163072) | Milton S. Hershey Medical Center | 2005-10-01 |
| Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss (NCT00899158) | Case Comprehensive Cancer Center | 2005-06-01 |
| The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance (NCT00172614) | National Taiwan University Hospital | 2004-12-01 |
| Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss (NCT00637572) | Endo USA Inc., a Keenova Therapeutics Company | 2004-12-01 |
| Creatine in Treating Patients With Cancer-Associated Weight Loss (NCT00081250) | Alliance for Clinical Trials in Oncology | 2004-12-01 |
| Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia (NCT00244192) | Center for Integrated Rehabilitation and Organ Failure Horn | 2003-10-01 |
| A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia (NCT00060502) | Centocor, Inc. | 2003-04-01 |
| Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer (NCT00053053) | Radiation Therapy Oncology Group | 2002-12-01 |
| Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) (NCT00040885) | Alliance for Clinical Trials in Oncology | 2002-10-01 |
| Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer (NCT00006799) | Wake Forest University Health Sciences | 2000-10-01 |
| Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors (NCT00014248) | Dartmouth-Hitchcock Medical Center | 2000-10-01 |
| Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer (NCT00031785) | Wake Forest University Health Sciences | 2000-09-01 |